PROCESS FOR THE PURIFICATION OF HEPARAN SULFATE AND USE THEREOF IN COSMETOLOGICAL AND DERMATOLOGICAL PREPARATIONS
    3.
    发明申请
    PROCESS FOR THE PURIFICATION OF HEPARAN SULFATE AND USE THEREOF IN COSMETOLOGICAL AND DERMATOLOGICAL PREPARATIONS 有权
    硫代硫酸盐的净化方法及其在化学和制药领域的应用

    公开(公告)号:US20110288047A1

    公开(公告)日:2011-11-24

    申请号:US13129030

    申请日:2009-09-29

    申请人: Luigi De Ambrosi

    发明人: Luigi De Ambrosi

    摘要: The present invention relates to cosmetological and dermatological compositions comprising heparan sulfate. The invention further discloses a process for the purification of heparan sulfate for dermatological and cosmetological applications, which process comprises the following steps: solubilization of heparan sulfate in water, adsorption on an anion exchange resin, desorption from the resin by using conditions which result in selective desorption of hepar an sulfate. The cosmetological and dermatological compositions according to the invention show, inter alia, anti-age, lenitive, and whitening effect.

    摘要翻译: 本发明涉及包含硫酸乙酰肝素的美容和皮肤病学组合物。 本发明还公开了一种用于皮肤病学和美容应用的硫酸乙酰肝素的纯化方法,该方法包括以下步骤:将硫酸乙酰肝素溶解于水中,在阴离子交换树脂上吸附,通过使用导致选择性的条件从树脂中解吸 肝素硫酸盐解吸。 根据本发明的美容和皮肤病学组合物尤其表现出抗衰老,延缓和美白效果。

    Extracting protease-inhibitor from animal tissue containing same
    7.
    发明授权
    Extracting protease-inhibitor from animal tissue containing same 失效
    从含有它的动物组织中提取蛋白酶抑制剂

    公开(公告)号:US4216293A

    公开(公告)日:1980-08-05

    申请号:US916536

    申请日:1978-06-19

    CPC分类号: C08B37/0066 C07K14/8117

    摘要: Protease inhibitor is extracted from fresh or frozen organs of slaughtered animals by an enzymolysis operation which excludes any possibility of interference by azymic autolysis, the enzymolysis being stopped after a time not exceeding 4 hours, whereafter a lysate aqueous solution is obtained by filtration and a quaternary ammonium base is added to the lysate solution to precipitate insolubles, the filtrate being the fraction which contains the expected protease inhibitor.

    摘要翻译: 通过酶解操作从屠宰动物的新鲜或冷冻器官中提取蛋白酶抑制剂,其排除任何可能的干扰自由酶的可能性,在不超过4小时的时间后停止酶解,然后通过过滤获得裂解物水溶液, 将铵碱加入裂解液中以沉淀不溶物,滤液为含有预期蛋白酶抑制剂的级分。

    Process for the controlled preparation of low molecular weight
glucosaminoglycans
    9.
    发明授权
    Process for the controlled preparation of low molecular weight glucosaminoglycans 失效
    用于控制制备低分子量葡糖胺聚糖的方法

    公开(公告)号:US4987222A

    公开(公告)日:1991-01-22

    申请号:US120953

    申请日:1987-11-16

    摘要: A process for the controlled preparation of low molecular weight glucosaminoglycans by treating conventional high molecular weight glucosaminoglycans in the solid state or in solution form with a rectilinear gamma ray beam at doses within the range of 2.5 to 20 Mrad supplied by successive irradiation stages with cooling intervals between one irradiation stage and the next in the dynamic phase.The mixture obtained is subjected to fractionation, purification, neutralization and lyophilization. The glucosaminoglycans obtained have a molecular weight of between 1000 and 35,000 daltons and are used for the preparation of pharmaceutical compositions possessing antithrombotic, fibinolytic, antiatherogenic and heparin cofactor II activation activity.

    摘要翻译: 通过用连续照射阶段提供的剂量在2.5至20Mrad范围内的剂量处理固体状态或溶液形式的常规高分子量葡糖胺聚糖与冷却间隔来控制制备低分子量葡糖胺聚糖的方法 在一个辐射阶段和下一个在动态阶段之间。 将得到的混合物进行分馏,纯化,中和和冻干。 获得的葡糖胺聚糖具有1000至35,000道尔顿之间的分子量,并且用于制备具有抗血栓形成,纤维蛋白溶解,抗动脉粥样化和肝素辅因子II活化活性的药物组合物。